AFP Test: Liver Health & Prenatal Screening Guide

What is AFP?

Alpha-Fetoprotein (AFP) is a protein normally produced by the fetal liver during development. After birth, AFP levels drop rapidly and are normally very low in healthy adults.

AFP in Different Contexts

In Adults:

• Normally very low (＜ 15 ng/mL)
• Tumor marker for certain cancers
• Indicator of liver damage
• Used for cancer monitoring

In Pregnancy:

• Produced by fetal liver
• Crosses into mother's bloodstream
• Used for prenatal screening
• Screens for neural tube defects and chromosomal problems

AFP Testing by Purpose

1. Cancer Screening & Monitoring

Primary Uses:

• Liver cancer (hepatocellular carcinoma) screening
• Monitoring treatment response
• Detecting cancer recurrence
• Germ cell tumor monitoring

Who Gets Tested:

• Chronic hepatitis B or C
• Liver cirrhosis
• History of liver cancer
• Alcohol-related liver disease
• Non-alcoholic fatty liver disease (NAFLD)

2. Prenatal Screening

What It Screens For:

• Neural tube defects (spina bifida, anencephaly)
• Abdominal wall defects
• Chromosomal abnormalities (Down syndrome - low AFP)
• Multiple pregnancies (high AFP)

When It's Performed:

• Maternal serum AFP test: 15-20 weeks gestation
• Part of quad screen or triple screen
• Combined with other markers for accuracy

AFP Reference Ranges

Adults (Non-Pregnant)

| Category | AFP Level (ng/mL) | Significance | |----------|-------------------|--------------| | Normal | 0 - 10 | Healthy liver, no cancer detected | | Borderline | 10 - 20 | May need monitoring, repeat testing | | Elevated | 20 - 100 | Liver damage, possible tumor | | Significantly Elevated | 100 - 400 | Concerning for cancer | | Very High | ＞ 400 | Strongly suggests malignancy |

Pregnancy (Maternal Serum)

| Gestational Age | Expected AFP Range (MoM*) | |-----------------|-------------------------| | 15-16 weeks | 0.5 - 2.0 MoM | | 16-18 weeks | 0.5 - 2.0 MoM | | 18-20 weeks | 0.5 - 2.0 MoM |

*MoM = Multiple of the Median, adjusted for week of pregnancy

Understanding High AFP

In Adults

Elevated AFP May Indicate:

Liver Conditions:

• Hepatocellular carcinoma (liver cancer)
• Liver cirrhosis
• Acute or chronic hepatitis
• Liver regeneration after injury

Other Cancers:

• Germ cell tumors (testicular, ovarian)
• Stomach cancer
• Pancreatic cancer
• Lung cancer (rarely)

Non-Cancer Causes:

• Pregnancy (in women)
• Recent liver injury or surgery
• Certain medications

In Pregnancy

High AFP (> 2.0 MoM) May Indicate:

• Neural tube defects:
  • Spina bifida
  • Anencephaly
  • Encephalocele
• Abdominal wall defects:
  • Omphalocele
  • Gastroschisis
• Multiple pregnancies (twins, triplets)
• Incorrect dating (pregnancy further along than thought)
• Fetal loss (if previously pregnant)

Understanding Low AFP

In Adults

Low AFP is typically not concerning and doesn't have clinical significance in most cases.

In Pregnancy

Low AFP (< 0.5 MoM) May Indicate:

• Down syndrome (Trisomy 21)
• Other chromosomal abnormalities:
  • Trisomy 18 (Edwards syndrome)
  • Trisomy 13 (Patau syndrome)
• Incorrect dating (pregnancy less far along than thought)
• Fetal loss

AFP Testing Process

Before the Test

Preparation:

• No fasting required for AFP blood test
• No special preparation needed
• Can be done any time of day
• Tell your doctor about:
  • Pregnancy status
  • Recent pregnancy or miscarriage
  • Liver disease history
  • Current medications

During the Test

Blood Draw:

• Simple blood draw from arm
• Takes 5-10 minutes
• Can be done at lab or doctor's office
• Results typically available in 1-3 days

Cost and Insurance

| Setting | Typical Cost | Insurance Coverage | |---------|--------------|-------------------| | With doctor's order | $30 - $80 | Often covered for monitoring | | Direct-to-consumer | $50 - $100 | Usually not covered | | Part of prenatal panel | Included in screen | Typically covered |

AFP and Liver Cancer

Primary Use: Hepatocellular Carcinoma (HCC)

Why AFP for Liver Cancer:

• 70% of liver cancers produce AFP
• Levels correlate with tumor size
• Useful for monitoring treatment response
• Detects recurrence earlier than imaging

AFP Levels in Liver Cancer: | AFP Level | Likelihood of HCC | |-----------|-------------------| | ＜ 20 ng/mL | Low (but possible) | | 20 - 200 ng/mL | Moderate | | 200 - 400 ng/mL | High | | ＞ 400 ng/mL | Very high |

Monitoring Treatment:

• AFP should decrease with successful treatment
• Rising AFP indicates recurrence or progression
• Used alongside imaging for complete picture

Who Should Get Screened

High-Risk Groups (Screen Every 6 Months):

• Chronic hepatitis B
• Chronic hepatitis C
• Liver cirrhosis (any cause)
• Alcohol-related liver disease
• NAFLD with advanced fibrosis
• Family history of liver cancer

AFP and Prenatal Screening

Maternal Serum AFP (MSAFP) Screening

What It Tests For:

• Neural tube defects (spina bifida, anencephaly)
• Abdominal wall defects
• Chromosomal abnormalities (when combined with other markers)

When It's Done:

• 15-20 weeks gestation (optimal: 16-18 weeks)
• Part of quad screen (AFP + hCG + estriol + inhibin A)
• One simple blood draw from mother's arm

Understanding Your Results

Normal AFP (0.5 - 2.0 MoM):

• 95% of babies are healthy
• Screening doesn't detect all problems
• No further testing typically needed

High AFP (> 2.0 MoM):

• Most common cause: Normal baby + incorrect dating
• More concerning: Neural tube defect possible
• Follow-up needed:
  • Detailed anatomy ultrasound (level II)
  • Possible amniocentesis
  • Repeat AFP testing

Low AFP (< 0.5 MoM):

• May indicate Down syndrome
• Follow-up with:
  • Detailed ultrasound
  • Cell-free DNA screening (NIPT)
  • Possible amniocentesis

What Happens After Abnormal AFP

Step 1: Confirm Dating

• Ultrasound to confirm gestational age
• Many abnormal AFP results are due to wrong dates

Step 2: Detailed Ultrasound

• Level II ultrasound (detailed anatomy survey)
• Looks for neural tube defects
• Examines baby's spine, skull, abdomen

Step 3: Additional Testing (if indicated)

• Amniocentesis (genetic testing)
• Amniotic fluid AFP
• Acetylcholinesterase testing
• Genetic counseling

AFP Limitations

Not Perfect

False Positives:

• Incorrect dating (most common)
• Multiple pregnancy
• Fetal normal variation
• Lab error (rare)

False Negatives:

• Not all neural tube defects elevate AFP
• Not all cancers produce AFP
• Small tumors may not raise AFP significantly

Not All Cancers Produce AFP:

• Only 70% of liver cancers produce AFP
• Some liver cancers are AFP-negative
• Other tumor markers may be needed

Improving AFP Accuracy

Before Testing

For Accurate Results:

• Confirm pregnancy dating if prenatal
• Know your medical history
• List all medications
• For liver monitoring: consistent testing intervals

Follow-Up Testing

If AFP Elevated:

• Repeat test in 2-4 weeks
• Imaging (ultrasound, CT, MRI)
• Clinical correlation with symptoms
• Consider other tumor markers

Frequently Asked Questions

Does high AFP mean I have cancer?

Not necessarily. Elevated AFP can be caused by:

• Liver disease (not cancer)
• Recent liver injury
• Pregnancy (in women)
• Benign liver tumors
• Lab variation

Follow-up testing determines the cause.

Is AFP screening recommended for everyone?

No. AFP screening is recommended for:

• High-risk liver disease patients
• Pregnant women (as part of prenatal screening)
• Cancer patients (for monitoring)

General population screening is not recommended.

Can AFP be normal and still have liver cancer?

Yes. About 30% of liver cancers don't produce AFP. This is why imaging (ultrasound, CT, MRI) is essential alongside AFP monitoring.

How quickly does AFP change?

• With successful cancer treatment: AFP should decrease by half (50%) every 1-2 months
• With recurrence: AFP can rise over weeks to months
• With liver injury: Temporary elevation, returns to baseline

Should I worry about low AFP?

In adults: No, low AFP is not typically concerning. In pregnancy: Low AFP may indicate chromosomal abnormalities and requires follow-up.

Related Testing

For Liver Cancer Screening:

• Liver ultrasound every 6 months
• CT or MRI if AFP elevated
• Liver function tests (ALT, AST)
• Fibrosis assessment

For Prenatal Care:

• Detailed anatomy ultrasound
• Cell-free DNA screening (NIPT)
• Quad screen (AFP + 3 other markers)
• Genetic counseling if needed

---

Bottom Line

AFP is a valuable screening tool in two contexts:

In Adults:

• ✅ Liver cancer screening for high-risk patients
• ✅ Monitoring treatment response
• ✅ Detecting recurrence
• ❌ Not diagnostic alone
• ❌ Not for general population screening

In Pregnancy:

• ✅ Neural tube defect screening
• ✅ Part of chromosomal abnormality screening
• ✅ Identifies high-risk pregnancies
• ❌ Requires follow-up testing
• ❌ Most abnormal results have normal explanations

Best approach: Use AFP as one piece of information. Results should always be interpreted by a qualified healthcare provider in the context of your complete medical picture.

Medical Disclaimer: This information is educational. Consult your healthcare provider for personalized interpretation of AFP results and appropriate follow-up care.